(Q43240879)

17 November 2017

VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis (English)

1 reference

17 November 2017

1 reference

1 reference

1 reference

1 reference

Tian Xiao

1

1 reference

17 November 2017

Jun Kai Fan

2

1 reference

17 November 2017

Hong Ling Huang

3

1 reference

17 November 2017

Jin Fa Gu

4

1 reference

17 November 2017

Lu-Yuan Li

5

1 reference

17 November 2017

Xin Yuan Liu

6

1 reference

17 November 2017

17 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

20

1 reference

17 November 2017

367-378

1 reference

17 November 2017

3

1 reference

https://scigraph.springernature.com/pub.10.1038/cr.2009.126

17 November 2017

0 references

cites work

Blood vessel formation: what is its molecular basis?

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Modulation of endothelial cell growth arrest and apoptosis by vascular endothelial growth inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Vascular endothelial growth inhibitor (VEGI), an endogenous negative regulator of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Reduced vascular endothelial growth inhibitor (VEGI) expression is associated with poor prognosis in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

The T cell costimulator TL1A is induced by FcgammaR signaling in human monocytes and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Association study of TNFSF15 polymorphisms in Japanese patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

TNFSF15 is an ethnic-specific IBD gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Oncolytic adenovirus-mediated shRNA against Apollon inhibits tumor cell growth and enhances antitumor effect of 5-fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

VEGI, a new member of the TNF family activates nuclear factor-kappa B and c-Jun N-terminal kinase and modulates cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Caspase-8 sumoylation is associated with nuclear localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Pro-caspase-3 is a major physiologic target of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

TL1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase) and caspase-3-like protease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

E1A is sufficient by itself to induce apoptosis independent of p53 and other adenoviral gene products.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

A rapid and simple method for the isolation of apoptotic DNA fragments.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

Transplacental carcinogenesis by stilbestrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

7 January 2021

VEGI, a novel cytokine of the tumor necrosis factor family, is an angiogenesis inhibitor that suppresses the growth of colon carcinomas in vivo

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

7 January 2021

Inhibition of angiogenesis and breast cancer xenograft tumor growth by VEGI, a novel cytokine of the TNF superfamily

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

7 January 2021

A novel secreted splice variant of vascular endothelial cell growth inhibitor

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

7 January 2021

Effective gene-virotherapy for complete eradication of tumor mediated by the combination of hTRAIL (TNFSF10) and plasminogen k5

1 reference

https://api.crossref.org/works/10.1038%2FCR.2009.126

7 January 2021

Identifiers

DOI

10.1038/CR.2009.126

1 reference

Dimensions Publication ID

17 November 2017

0 references

1 reference